Hannu Kankaanranta

Medicine & Life Sciences

1. Asthma 100%
2. Finland 37%
3. Sweden 30%
4. Population 22%
5. Estonia 20%
6. Chronic Obstructive Pulmonary Disease 17%
7. Adrenal Cortex Hormones 13%
8. Social Class 13%
9. Smoking 12%
10. 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole 12%
11. Odds Ratio 11%
12. Dust 11%
13. Occupational Exposure 10%
14. Cross-Sectional Studies 10%
15. Dyspnea 10%
16. Genome-Wide Association Study 9%
17. Multimorbidity 9%
18. Bronchodilator Agents 9%
19. Rhinitis 9%
20. Gases 8%
21. Fees and Charges 8%
22. Life Style 8%
23. Physicians 8%
24. Idiopathic Pulmonary Fibrosis 8%
25. Agriculture 8%
26. Eczema 7%
27. Women's Health 7%
28. Treatment Adherence and Compliance 7%
29. Sleep Apnea Syndromes 7%
30. Obstructive Sleep Apnea 7%
31. Smoke 7%
32. Tobacco 7%
33. Occupations 6%
34. Hematopoietic Stem Cells 6%
35. Intraocular Pressure 6%
36. Biomarkers 6%
37. Habits 6%
38. Glaucoma 6%
39. Cough 6%
40. Statistical Factor Analysis 6%
41. Scandinavian and Nordic Countries 6%
42. Non-Steroidal Anti-Inflammatory Agents 6%
43. Registries 5%
44. Lung 5%
45. Cohort Studies 5%
46. Steroids 5%
47. Confidence Intervals 5%
48. Anti-Inflammatory Agents 5%